Screening and Prostate-Cancer Mortality in a Randomized European Study
|
journal
|
March 2009 |
Cancer statistics, 2013
|
journal
|
January 2013 |
Molecular Imaging of Prostate Cancer: PET Radiotracers
|
journal
|
August 2012 |
Imaging Prostate Cancer: A Multidisciplinary Perspective
|
journal
|
April 2007 |
Detection of bone metastases in patients with prostate cancer by 18F fluorocholine and 18F fluoride PET–CT: a comparative study
|
journal
|
May 2008 |
Skeletal PET with18F-Fluoride: Applying New Technology to an Old Tracer
|
journal
|
December 2007 |
Androgen deprivation therapy: progress in understanding mechanisms of resistance and optimizing androgen depletion
|
journal
|
February 2009 |
Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1–2 study
|
journal
|
April 2010 |
Structure−Activity Relationship for Thiohydantoin Androgen Receptor Antagonists for Castration-Resistant Prostate Cancer (CRPC)
|
journal
|
April 2010 |
Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer
|
journal
|
May 2009 |
Noninvasive measurement of androgen receptor signaling with a positron-emitting radiopharmaceutical that targets prostate-specific membrane antigen
|
journal
|
May 2011 |
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
|
journal
|
September 2012 |
Mechanisms of persistent activation of the androgen receptor in CRPC: recent advances and future perspectives
|
journal
|
October 2011 |
Androgen Receptor Splice Variants Activate Androgen Receptor Target Genes and Support Aberrant Prostate Cancer Cell Growth Independent of Canonical Androgen Receptor Nuclear Localization Signal
|
journal
|
June 2012 |
Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant
|
journal
|
August 2010 |
Expression of the gastrin-releasing peptide receptor, the prostate stem cell antigen and the prostate-specific membrane antigen in lymph node and bone metastases of prostate cancer
|
journal
|
April 2009 |
Prostate Stem Cell Antigen Is Overexpressed in Prostate Cancer Metastases
|
journal
|
April 2005 |
Expression of prostate stem cell antigen in high-grade prostatic intraepithelial neoplasia and prostate cancer
|
journal
|
October 2010 |
Prostate Stem Cell Antigen (PSCA) Expression in Human Prostate Cancer Tissues: Implications for Prostate Carcinogenesis and Progression of Prostate Cancer
|
journal
|
July 2004 |
Prostate stem cell antigen (PSCA) expression increases with high gleason score, advanced stage and bone metastasis in prostate cancer
|
journal
|
March 2000 |
Prostate Stem Cell Antigen Expression is Associated With Gleason Score, Seminal Vesicle Invasion and Capsular Invasion in Prostate Cancer
|
journal
|
March 2004 |
Prostate stem cell antigen: A cell surface marker overexpressed in prostate cancer
|
journal
|
February 1998 |
Coamplification of prostate stem cell antigen (PSCA) andMYC in locally advanced prostate cancer
|
journal
|
January 2000 |
Peripheral blood reverse transcription PCR assay for prostate stem cell antigen correlates with androgen-independent progression in advanced prostate cancer
|
journal
|
November 2011 |
Identification of an Androgen-Dependent Enhancer within the Prostate Stem Cell Antigen Gene
|
journal
|
October 2002 |
Flutamide reduced prostate cancer development and prostate stem cell antigen mRNA expression in high grade prostatic intraepithelial neoplasia
|
journal
|
February 2008 |
Complete androgen ablation suppresses prostate stem cell antigen (PSCA) mRNA expression in human prostate carcinoma
|
journal
|
December 2005 |
Advances in Immuno–Positron Emission Tomography: Antibodies for Molecular Imaging in Oncology
|
journal
|
November 2012 |
Quantitative ImmunoPET of Prostate Cancer Xenografts with 89Zr- and 124I-Labeled Anti-PSCA A11 Minibody
|
journal
|
February 2014 |
An affinity matured minibody for PET imaging of prostate stem cell antigen (PSCA)-expressing tumors
|
journal
|
April 2010 |
Characterization of Osteolytic, Osteoblastic, and Mixed Lesions in a Prostate Cancer Mouse Model Using 18F-FDG and 18F-Fluoride PET/CT
|
journal
|
February 2008 |
Differences in the cytokine profiles associated with prostate cancer cell induced osteoblastic and osteolytic lesions in bone
|
journal
|
January 2003 |
AMIDE: A Free Software Tool for Multimodality Medical Image Analysis
|
journal
|
July 2003 |
OsiriX: An Open-Source Software for Navigating in Multidimensional DICOM Images
|
journal
|
June 2004 |
Anti–Prostate Stem Cell Antigen Monoclonal Antibody 1G8 Induces Cell Death In vitro and Inhibits Tumor Growth In vivo via a Fc-Independent Mechanism
|
journal
|
October 2005 |
A Novel Dual-targeted Lentiviral Vector Leads to Specific Transduction of Prostate Cancer Bone Metastases In Vivo After Systemic Administration
|
journal
|
November 2007 |
Influence of BMPs on the Formation of Osteoblastic Lesions in Metastatic Prostate Cancer
|
journal
|
August 2005 |
The effects of RANK blockade and osteoclast depletion in a model of pure osteoblastic prostate cancer metastasis in bone
|
journal
|
November 2005 |
The Bisphosphonate YM529 Inhibits Osteolytic and Osteoblastic Changes and CXCR-4–Induced Invasion in Prostate Cancer
|
journal
|
October 2005 |
In vivo Models of Prostate Cancer Metastasis to bone
|
journal
|
September 2005 |
Whole-body skeletal imaging in mice utilizing microPET: optimization of reproducibility and applications in animal models of bone disease
|
journal
|
July 2002 |
Imaging Androgen Receptor Signaling with a Radiotracer Targeting Free Prostate-Specific Antigen
|
journal
|
March 2012 |
Androgen-Independent Prostate Cancer Is a Heterogeneous Group of Diseases
|
journal
|
December 2004 |
Quantitating Antibody Uptake In Vivo: Conditional Dependence on Antigen Expression Levels
|
journal
|
August 2010 |
Improved Modeling of In Vivo Kinetics of Slowly Diffusing Radiotracers for Tumor Imaging
|
journal
|
July 2014 |